Market closedADR
Zai Lab/$ZLAB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Zai Lab
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Ticker
$ZLAB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1,869
Website
Zai Lab Metrics
BasicAdvanced
$4B
-
-$2.60
1.08
-
Price and volume
Market cap
$4B
Beta
1.08
52-week high
$39.77
52-week low
$13.48
Average daily volume
1.2M
Financial strength
Current ratio
3.509
Quick ratio
2.903
Long term debt to equity
1.631
Total debt to equity
18.251
Interest coverage (TTM)
-125.16%
Management effectiveness
Return on assets (TTM)
-15.87%
Return on equity (TTM)
-31.41%
Valuation
Price to revenue (TTM)
9.035
Price to book
4.67
Price to tangible book (TTM)
5.02
Price to free cash flow (TTM)
-13.042
Growth
Revenue change (TTM)
49.59%
Earnings per share change (TTM)
-24.96%
3-year revenue growth (CAGR)
40.35%
3-year earnings per share growth (CAGR)
-30.00%
What the Analysts think about Zai Lab
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Zai Lab stock.
Zai Lab Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Zai Lab Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Zai Lab News
AllArticlesVideos
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
Business Wire·1 week ago
Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth
Seeking Alpha·2 weeks ago
Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks
Seeking Alpha·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Zai Lab stock?
Zai Lab (ZLAB) has a market cap of $4B as of April 04, 2025.
What is the P/E ratio for Zai Lab stock?
The price to earnings (P/E) ratio for Zai Lab (ZLAB) stock is 0 as of April 04, 2025.
Does Zai Lab stock pay dividends?
No, Zai Lab (ZLAB) stock does not pay dividends to its shareholders as of April 04, 2025.
When is the next Zai Lab dividend payment date?
Zai Lab (ZLAB) stock does not pay dividends to its shareholders.
What is the beta indicator for Zai Lab?
Zai Lab (ZLAB) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.